ArticleIn silico pharmacology2024

Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer's disease.

A S Sriranjini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.